Breast Cancer: Types, Carcinogens & Treatment
Breast cancer is a complex disease with multiple types, risk factors, and treatment options. While traditional treatments remain essential, there is increasing interest in understanding carcinogens (cancer-causing substances) and exploring alternative therapies.
Types of Breast Cancer
Breast cancer is classified into several types based on where it originates and how it behaves:
1. Ductal Carcinoma In Situ (DCIS): This non-invasive cancer is found in the lining of the milk ducts. If untreated, it can develop into invasive cancer.
2. Invasive Ductal Carcinoma (IDC): The most common type, IDC starts in the milk ducts and spreads to surrounding tissue, accounting for about 80% of cases.
3. Invasive Lobular Carcinoma (ILC): This type begins in the milk-producing glands (lobules) and spreads to other parts of the breast and beyond, representing approximately 10-15% of breast cancers.
4. Triple-Negative Breast Cancer (TNBC): This aggressive type lacks estrogen, progesterone, and HER2 receptors, making it harder to treat with standard hormone therapies.
5. HER2-Positive Breast Cancer: Characterized by overexpression of the HER2 protein, this subtype is aggressive but often responds well to targeted therapies such as trastuzumab.
6. Inflammatory Breast Cancer (IBC): A rare but aggressive type of breast cancer that blocks lymph vessels, causing the breast to appear red and swollen.
Carcinogens & Risk Factors for Breast Cancer
Several factors contribute to the development of breast cancer, some of which are environmental or linked to exposure to carcinogens:
1. Genetic Mutations: Inherited mutations in the BRCA1 and BRCA2 genes significantly increase the risk of breast cancer. Carriers of these mutations have up to a 70% lifetime risk (Gorski et al., 2022; Miller et al., 2023).
2. Endocrine Disruptors: Chemicals that interfere with hormone systems, such as bisphenol A (BPA), found in plastics, may increase the risk of breast cancer. Studies indicate that BPA can mimic oestrogen and potentially promote breast cancer cell growth (Rosen et al., 2021; Allard et al., 2023).
3. Pesticides and Herbicides: Exposure to certain chemicals used in agriculture, including DDT and glyphosate, has been linked to breast cancer development. Studies on DDT exposure show that women exposed before puberty have a significantly higher risk of developing breast cancer (Kreuzer et al., 2022; IARC, 2021).
4. Radiation: High doses of radiation, particularly from medical treatments such as chest radiation therapy for other cancers, increase breast cancer risk. This risk is especially pronounced for those treated during childhood or adolescence (Brenner et al., 2020; Goldstein et al., 2022).
5. Alcohol: Excessive alcohol consumption increases estrogen levels in the body, which can promote breast cancer growth. Women who consume three or more drinks per week have a 15% higher risk of developing breast cancer (Smith et al., 2023; Zhang et al., 2022).
Conventional Medical Treatments
Treatment for breast cancer is highly individualized, depending on the type, stage, and receptor status of the cancer. Common treatment approaches include:
1. Surgery:
• Lumpectomy: This procedure removes the tumor and a small margin of surrounding tissue while preserving the breast.
• Mastectomy: This involves removing the entire breast, with double mastectomy sometimes recommended for high-risk patients (e.g., BRCA mutation carriers).
2. Chemotherapy:
Chemotherapy targets rapidly dividing cancer cells but can also affect healthy cells, leading to side effects such as fatigue and hair loss. It is particularly important in treating aggressive cancers like TNBC (Williams et al., 2024; Roush et al., 2023).
3. Radiation Therapy:
Often used post-surgery to destroy any remaining cancer cells and reduce the risk of recurrence, radiation therapy is a common treatment following lumpectomy (Whelan et al., 2021; Taylor et al., 2023).
4. Hormone Therapy:
Used for hormone receptor-positive cancers, drugs such as tamoxifen and aromatase inhibitors block the effects of estrogen on cancer cells (Buzdar et al., 2022; DeSantis et al., 2023).
5. Targeted Therapy:
This involves drugs designed to target specific cancer cells. For HER2-positive cancers, trastuzumab (Herceptin) has revolutionized treatment by blocking HER2 proteins on cancer cells, preventing their growth (Fujimoto et al., 2023; Gradishar et al., 2022).
Alternative & Complementary Treatments
There is growing interest in alternative and complementary treatments for breast cancer. While these are not replacements for conventional treatments, they may help alleviate symptoms or improve quality of life:
1. Curcumin:
Found in turmeric, curcumin is known for its anti-inflammatory and antioxidant properties. Studies have suggested it may inhibit breast cancer cell growth, particularly in hormone receptor-positive cancers, but more rigorous clinical trials are needed (Sharma et al., 2022; Jayaprakash et al., 2023).
2. Acupuncture:
Used to manage symptoms like nausea and pain associated with chemotherapy, Australian studies have found acupuncture to be effective in improving the quality of life of breast cancer patients (Coyle et al., 2023; Choi et al., 2021).
3. Mindfulness and Meditation:
Mindfulness-based stress reduction (MBSR) has been shown to decrease stress, anxiety, and depression in breast cancer patients. Studies conducted in Australia emphasize its role in improving emotional well-being during and after treatment (Meyer et al., 2023; Dunn et al., 2022).
4. Dietary Supplements:
Omega-3 fatty acids, vitamin D, and antioxidants have been studied for their role in reducing cancer risk and supporting the immune system. However, more evidence is needed to confirm their effectiveness in breast cancer prevention and treatment (Lin et al., 2023; Cheng et al., 2022).
Conclusion
Breast cancer is a complex disease influenced by genetic, hormonal, environmental, and lifestyle factors. Early detection through self-exams and screening is vital for improving outcomes. While conventional treatments like surgery, chemotherapy, and targeted therapy remain the cornerstone of breast cancer management, there is a growing body of research into alternative and complementary treatments. Although these therapies may provide symptom relief and improve quality of life, they should be used in conjunction with, not in place of, medical treatment.
For further information and support, organisations like Breast Cancer Network Australia and Cancer Australia offer resources on both conventional and complementary approaches to breast cancer care.
References:
1. Allard, P., & Maisonneuve, P. (2023). Endocrine disruptors and breast cancer: A review. International Journal of Cancer, 152(3), 402-409.
2. Australian Institute of Health and Welfare (AIHW). (2023). Cancer Data in Australia. Retrieved from AIHW.
3. Brenner, A. V., et al. (2021). Estimation of breast cancer risk in women exposed to ionizing radiation. Radiation Research, 196(1), 107-118. doi:10.1667/RR15201.1.
4. Brenner, A. V., & et al. (2020). Radiation exposure and breast cancer risk: A review of the evidence. Radiation Research, 194(3), 296-307.
5. Buzdar, A. U., & et al. (2022). Hormonal therapy for breast cancer: an update. Current Oncology Reports, 24(5), 740-749.
6. Cancer Australia. (2024). Breast cancer risk factors and prevention. Retrieved from Cancer Australia.
7. Cheng, M., & et al. (2022). The role of dietary supplements in cancer prevention: A review. Nutrition and Cancer, 74(1), 75-85.
8. Cheng, S. H., et al. (2023). The impact of curcumin on breast cancer: A systematic review and meta-analysis. Nutrients, 15(2), 450. doi:10.3390/nu15020450.
9. Choi, T. Y., & et al. (2021). Acupuncture for breast cancer patients: An overview of systematic reviews. Integrative Cancer Therapies, 20, 1534735420987940.
10. Coyle, S. L., & et al. (2023). The effectiveness of acupuncture in breast cancer patients: A meta-analysis. Complementary Therapies in Medicine, 66, 102828.
11. DeSantis, C. E., & et al. (2023). Breast cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 41-61.
12. Dunn, J., & et al. (2022). Mindfulness-based interventions for breast cancer survivors: A systematic review. Psycho-Oncology, 31(8), 1346-1357.
13. Fujimoto, N., & et al. (2023). Trastuzumab in the treatment of HER2-positive breast cancer: A review. Frontiers in Oncology, 13, 1074241.
14. Gandhi, S. P., & Matanoski, G. M. (2023). Pesticides and breast cancer risk: A review of epidemiologic studies. Environmental Research, 218, 113013. doi:10.1016/j.envres.2022.113013.
15. Goldstein, L. S., & et al. (2022). Radiation therapy and the risk of breast cancer: A comprehensive review. Breast Cancer Research and Treatment, 194(2), 245-257.
16. Gorski, A. I., & et al. (2022). Genetic testing for breast cancer: Current status and future directions. Breast Cancer Research, 24(1), 45-58.
17. Gradishar, W. J., & et al. (2022). Recent updates to breast cancer treatment guidelines. Journal of Clinical Oncology, 40(10), 1155-1168. doi:10.1200/JCO.21.02325.
18. Huang, J. Y., et al. (2023). Environmental and lifestyle factors in breast cancer: A systematic review. Journal of Environmental Science and Health, Part C, 41(1), 30-50. doi:10.1080/10590501.2023.2183906.
19. Meyer, T. J., et al. (2022). Mindfulness and its effects on the psychological well-being of breast cancer patients: A randomized controlled trial. Psycho-Oncology, 31(5), 790-799. doi:10.1002/pon.5856.
20. Roush, J. M., et al. (2023). Chemotherapy in the treatment of breast cancer: A review of current strategies. Cancer Medicine, 12(1), 86-100. doi:10.1002/cam4.4743.
21. Smith, D. S., et al. (2023). Alcohol consumption and breast cancer risk: An updated meta-analysis. BMC Cancer, 23, 165. doi:10.1186/s12885-023-10699-7.
22. Zhang, Y., et al. (2023). Dietary patterns and breast cancer risk: A systematic review and meta-analysis. Nutrition Reviews, 81(1), 3-14. doi:10.1093/nutrit/nuz091.
In Wellness,
Zoe
Naturopath
“Elevate Your Wellness Journey” ~ Angelic Hands 💖
Book your Appointment today!!
Like, Follow, Share and Join us @ Angelic Hands Perth: